TITLE

Inhibition of TTR Aggregation-Induced Cell Death – A New Role for Serum Amyloid P Component

AUTHOR(S)
Andersson, Karin; Pokrzywa, Malgorzata; Dacklin, Ingrid; Lundgren, Erik
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Serum amyloid P component (SAP) is a glycoprotein that is universally found associated with different types of amyloid deposits. It has been suggested that it stabilizes amyloid fibrils and therefore protects them from proteolytic degradation. Methodology/Principal Findings: In this paper, we show that SAP binds not only to mature amyloid fibrils but also to early aggregates of amyloidogenic mutants of the plasma protein transthyretin (TTR). It does not inhibit fibril formation of TTR mutants, which spontaneously form amyloid in vitro at physiological pH. We found that SAP prevents cell death induced by mutant TTR, while several other molecules that are also known to decorate amyloid fibrils do not have such effect. Using a Drosophila model for TTR-associated amyloidosis, we found a new role for SAP as a protective factor in inhibition of TTR-induced toxicity. Overexpression of mutated TTR leads to a neurological phenotype with changes in wing posture. SAP-transgenic flies were crossed with mutated TTR-expressing flies and the results clearly confirmed a protective effect of SAP on TTR-induced phenotype, with an almost complete reduction in abnormal wing posture. Furthermore, we found in vivo that binding of SAP to mutated TTR counteracts the otherwise detrimental effects of aggregation of amyloidogenic TTR on retinal structure. Conclusions/Significance: Together, these two approaches firmly establish the protective effect of SAP on TTR-induced cell death and degenerative phenotypes, and suggest a novel role for SAP through which the toxicity of early amyloidogenic aggregates is attenuated.
ACCESSION #
87623985

 

Related Articles

  • Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease. Nalivaeva, Natalia N.; Belyaev, Nikolai D.; Kerridge, Caroline; Turner, Anthony J. // Frontiers in Aging Neuroscience;Sep2014, Vol. 6, p1 

    Abnormal elevation of amyloid β-peptide (Aβ) levels in the brain is the primary trigger for neuronal cell death specific to Alzheimer's disease (AD). It is now evident that Aβ levels in the brain are manipulable due to a dynamic equilibrium between its production from the amyloid...

  • Transthyretin Val30Met familial amyloid polyneuropathy: a considerably different clinical picture and natural course in endemic and non-endemic areas. Ikeda, Shu-ichi // Journal of Neurology, Neurosurgery & Psychiatry;Feb2012, Vol. 83 Issue 2, p121 

    The article offers information on familial amyloid polyneuropathy (FAP), a disease caused by a mutation in the transthyretin (TTR) gene, producing an amyloidogenic variant form of TTR (ATTR), thus leading to the designation of ATTR type FAP. At present FAP is treatable with liver transplantation...

  • Mass spectrometric identification of posttranslational modifications in transthyretin from human blood. Popov, I. A.; Starodubtseva, N. L.; Indeikina, M. I.; Kostyukevich, Yu. I.; Kononikhin, A. S.; Nikolaeva, M. I.; Kukaev, E. N.; Kozin, S. A.; Makarov, A. A.; Nikolaev, E. N. // Molecular Biology;Nov2013, Vol. 47 Issue 6, p885 

    Transthyretin, one of the major blood proteins, displays a variety of posttranslational modifications, including those related to the development of grave diseases, such as Alzheimer’s disease, and familial amyloid polyneuropathy. A combined analytical technique based on the use of two...

  • Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) Activation. Sousa, Mónica Mendes; Du Yan, Shi; Stern, David; Saraiva, Maria Joào // Laboratory Investigation (00236837);Jul2000, Vol. 80 Issue 7, p1101 

    Mutated transthyretin (TTR) fibrils are associated with the pathology of familial amyloidotic polyneuropathy (FAP), in which extracellular amyloid deposits lead to degeneration of cells and tissues, in particular neurons of the peripheral nerve. Here we present evidence that the receptor for...

  • Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis. Palaninathan, Satheesh K.; Mohamedmohaideen, Nilofar N.; Orlandini, Elisabetta; Ortore, Gabriella; Nencetti, Susanna; Lapucci, Annalina; Rossello, Armando; Freundlich, Joel S.; Sacchettini, James C. // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Transthyretin (TTR) is one of thirty non-homologous proteins whose misfolding, dissociation, aggregation, and deposition is linked to human amyloid diseases. Previous studies have identified that TTR amyloidogenesis can be inhibited through stabilization of the native tetramer state by small...

  • Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis. Palaninathan, Satheesh K.; Mohamedmohaideen, Nilofar N.; Orlandini, Elisabetta; Ortore, Gabriella; Nencetti, Susanna; Lapucci, Annalina; Rossello, Armando; Freundlich, Joel S.; Sacchettini, James C. // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Transthyretin (TTR) is one of thirty non-homologous proteins whose misfolding, dissociation, aggregation, and deposition is linked to human amyloid diseases. Previous studies have identified that TTR amyloidogenesis can be inhibited through stabilization of the native tetramer state by small...

  • NMR Structure of the Human Prion Protein with the Pathological Q212P Mutation Reveals Unique Structural Features. Ilc, Gregor; Giachin, Gabriele; Jaremko, Mariusz; Jaremko, Lukasz; Benetti, Federico; Plavec, Janez; Zhukov, Igor; Legname, Giuseppe // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Prion diseases are fatal neurodegenerative disorders caused by an aberrant accumulation of the misfolded cellular prion protein (PrPC) conformer, denoted as infectious scrapie isoform or PrPSc. In inherited human prion diseases, mutations in the open reading frame of the PrP gene (PRNP) are...

  • Molecules Block Heart Amyloid. Hampton, Tracy // JAMA: Journal of the American Medical Association;10/5/2011, Vol. 306 Issue 13, p1431 

    The article reports on the discovery of small molecules capable of treating cardiac amyloid diseases caused by aggregates of the protein transthyretin in a study published in a 2011 issue of "Science Translational Medicine."

  • Further considerations on in vitro skeletal muscle cell death. Battistelli, Michela; Salucci, Sara; Burattini, Sabrina; Falcieri, Elisabetta // Muscles, Ligaments & Tendons Journal (MLTJ);2013, Vol. 3 Issue 4, p267 

    The present review discusses the apoptotic behavior induced by chemical and physical triggers in C2C12 skeletal muscle cells, comparing myoblast to myotube sensitivity, and investigating it by means of morphological, biochemical and cytofluorimetric analyses. After all treatments, myotubes,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics